Cipher Pharmaceuticals Inc.
CPH.TO
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 298.06% | 1,843.82% | 96.76% | -46.70% | -56.32% |
| Total Depreciation and Amortization | 19.06% | -6.75% | 518.84% | 530.45% | 453.48% |
| Total Amortization of Deferred Charges | 15.38% | 77.27% | -- | -- | -- |
| Total Other Non-Cash Items | -112.88% | -1,280.00% | -830.00% | 54.39% | -631.55% |
| Change in Net Operating Assets | -72.09% | 1,575.40% | -132.32% | 113.57% | 228.51% |
| Cash from Operations | -1.77% | 437.36% | -3.29% | 73.38% | 267.60% |
| Capital Expenditure | -257.14% | 100.00% | 100.00% | 66.67% | 95.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1,585.71% | 100.06% | 100.00% | 66.67% | 95.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -11,452.86% | -11,282.08% | -51,893.10% | -171.43% | -94.44% |
| Issuance of Common Stock | 760.00% | 350.00% | -58.33% | -69.90% | -92.35% |
| Repurchase of Common Stock | -- | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -9,146.15% | -134.43% | -344,120.00% | 55.45% | 97.90% |
| Foreign Exchange rate Adjustments | 116.27% | -334.62% | 357.28% | 94.15% | -213.27% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -111.20% | 92.42% | -277.59% | 93.09% | 467.67% |